Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis

Journal of Translational Medicine

Yinyan He¹  Wenyin Shi²  Shivank Garg²  Xingyu Mu³  Zhixian Yao³  Wu Ke³  Zhong Zheng³  Renjie Wang³  Xiang Wang³  Feng Sun³  Zhihong Liu³ 

[1] Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine;Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center;Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine;

关键词: Bladder cancer;    Brain metastasis;    Machine learning;    Nomogram;    Overall survival;   

DOI  :  10.1186/s12967-019-2109-7

来源: DOAJ

【 摘 要 】

Abstract Background This study aimed to establish and validate a nomogram for predicting brain metastasis in patients with bladder cancer (BCa) and assess various treatment modalities using a primary cohort comprising 234 patients with clinicopathologically-confirmed BCa from 2004 to 2015 in the National Cancer Database. Methods Machine learning method and Cox model were used for nomogram construction. For BCa patients with brain metastasis, surgery of the primary site, chemotherapy, radiation therapy, palliative care, brain confinement of metastatic sites, and the Charlson/Deyo Score were predictive features identified for building the nomogram. Results For the original 169 patients considered in the model, the areas under the receiver operating characteristic curve (AUC) were 0.823 (95% CI 0.758–0.889, P < 0.001) and 0.854 (95% CI 0.785–0.924, P < 0.001) for 0.5- and 1-year overall survival respectively. In the validation cohort, the nomogram displayed similar AUCs of 0.838 (95% CI 0.738–0.937, P < 0.001) and 0.809 (95% CI 0.680–0.939, P < 0.001), respectively. The high and low risk groups had median survivals of 1.91 and 5.09 months for the training cohort and 1.68 and 8.05 months for the validation set, respectively (both P < 0.0001). Conclusions Our prognostic nomogram provides a useful tool for overall survival prediction as well as assessing the risk and optimal treatment for BCa patients with brain metastasis.

【 授权许可】

Unknown